会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 100. 发明申请
    • D, L-CYCLIC PEPTIDE NANOTUBE REINFORCING AGENTS
    • D,L循环肽纳米粒子增强剂
    • US20140369954A1
    • 2014-12-18
    • US14360851
    • 2012-11-26
    • Neel Satish JoshiDaniel James Rubin
    • Neel Satish JoshiDaniel James Rubin
    • A61L27/22A61L27/26D01D5/00A61L27/44
    • A61L27/227A61K9/0092A61K47/42A61L27/18A61L27/26A61L27/44A61L31/125A61L31/129A61L2400/12A61L2430/02A61L2430/10A61L2430/34A61L2430/38B82Y30/00B82Y40/00C08K7/22C08K2201/011C08L1/02C08L5/04C08L5/08C08L89/00D01D5/0053D10B2331/041Y10T428/249921C08L67/04C08L101/16
    • The disclosed subject matter can provide a nanotube-reinforced polymer composite material comprising a plurality of nanotubes, each nanotube being formed of a plurality of cyclic peptide molecules, disposed within a polymer matrix, such as a biodegradable polymer matrix. A cyclic polymer, such as a cyclic 8-mer, composed of amino acid residues of alternating absolute configurations (D/L, R/S), can self-assemble into nanotubes useful for preparation of the composite polymer material of the invention. For example, the cyclic peptide (QL)4, wherein the glutamine and leucine residues are of opposite absolute configuration, self-assembles into nanotubes, which when formed into a reinforced polymer composite including poly(caprolactone), provides a biocompatible material of greater tensile strength and Young's modulus compared to the poly(caprolactone) material alone. The nanotubes can be prepared by a vapor equilibration technique or by a solvent-nonsolvent precipitation technique. The materials of the invention can be used for implants, stents and the like as well as for synthetic ligaments, tendons, cartilage, and bone for use in the living tissue of a patient in need thereof. For example, a spinal fusion cage comprising a PDLLA polymer matrix with a plurality of nanotubes of the invention can exhibit enhanced stiffness.
    • 所公开的主题可以提供包含多个纳米管的纳米管增强聚合物复合材料,每个纳米管由多个环状肽分子形成,设置在聚合物基质例如可生物降解的聚合物基质内。 由交替绝对构型(D / L,R / S)的氨基酸残基组成的环状聚合物如环状8-聚体可以自组装成可用于制备本发明的复合聚合物材料的纳米管。 例如,其中谷氨酰胺和亮氨酸残基具有相反绝对构型的环肽(QL)4自组装成纳米管,当其形成包含聚(己内酯)的增强聚合物复合物时,其提供了更大拉伸的生物相容性材料 强度和杨氏模量与单独的聚(己内酯)材料相比。 纳米管可以通过蒸汽平衡技术或溶剂 - 非溶剂沉淀技术制备。 本发明的材料可用于植入物,支架等,以及用于需要其的患者的生物体组织中的合成韧带,腱,软骨和骨骼。 例如,包含具有本发明的多个纳米管的PDLLA聚合物基质的脊柱融合器可以表现出增强的刚度。